Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

Alzheimer’s disease (AD) is a large and increasing unmet medical need with no disease-modifying treatment currently available. Genetic evidence from genome-wide association studies (GWASs) and gene network analysis has clearly revealed a key role of the innate immune system in the brain, of which mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Biber, Knut, Bhattacharya, Anindya, Campbell, Brian M., Piro, Justin R., Rohe, Michael, Staal, Roland G.W., Talanian, Robert V., Möller, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716448/
https://www.ncbi.nlm.nih.gov/pubmed/31507408
http://dx.doi.org/10.3389/fphar.2019.00840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716448/
https://www.ncbi.nlm.nih.gov/pubmed/31507408
http://dx.doi.org/10.3389/fphar.2019.00840

Ejemplares similares